Our Company

Recognizing the plethora of potential first- and best-in-class candidates out of China and other geographic areas such as Europe, South Korea and Japan—and the risk that these might never make it to market due to development challenges in the areas in which they were discovered—we have made it our mission to ensure these innovations get into the hands of patients and physicians across the globe.

This is R&D
Done Differently

Our Process


We source scientifically validated first- and/or best-in-class discoveries from around the globe

Our close relationship with Chinese biopharma provides expanded BD opportunities, with unparalleled sourcing, access and clinical/scientific due diligence capabilities


Partner & Collaborate

We establish partnerships to license the candidate and work closely with the innovators to maximize its therapeutic and market potential

Our management team has deep experience and proven track records in BD execution across global and Chinese biopharma companies

Partner & Collaborate


We are experts at expedient, efficient drug development, ushering product candidates rapidly through the clinic to approval for patients presently lacking treatment options

Our team has extensive experience interacting with the FDA and successfully advancing pipeline assets through regulatory pathways in the U.S.

Development - image of woman looking out window

Our Leadership

We are industry leaders with proven track records of drug development and bringing
important medicines to market


years of Director level experience at U.S. large pharma


drugs entered into registrational studies by management in key roles


FDA approvals achieved by management in key roles


We would welcome discussions on
meaningful strategic collaborations.

Our Investors